Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-03-05
2010-02-02
Saeed, Kamal A (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S252010, C514S256000, C514S275000, C544S330000, C544S336000
Reexamination Certificate
active
07655663
ABSTRACT:
The present invention relates to new, potent DPP-IV enzyme inhibitors of the general formula (I), which contain fluorine atoms.
REFERENCES:
patent: 2004/0024236 (2004-02-01), Vanduffel
patent: 2004/0242636 (2004-12-01), Haffner et al.
patent: 2005/0176771 (2005-08-01), Hayakawa
patent: PCT/JP03/09179 (2003-07-01), None
patent: PCT/JP03/09179 (2005-08-01), None
“Tautomer.” Retrieved online via the Internet [Dec. 9, 2008] URL:www.en.wikipedia.org/wiki/Tautomer.
“Isomer.” Retrieved online via the Internet [Dec. 9, 2008] URL: www.en.wikipedia.org/wiki/isomer.
Patani, George A. Bioisosterism: A rational approach in drug design. Chem. Rev. 96 (1996) 3147-3176.
Morissette et al. Advanced Drug Delivery Reviews 2004, 56, 275-300.
Vippagunta et al., abstract, Vippagunta, Sudha R. “Crystalline Solids.” Advanced Drug Delivery Reviews 48(2001): 3-26.
Aranyi Peter
Balazs Laszlo
Bata Imre
Batori Sandor
Boronkay Eva
Morrill Brian R.
Saeed Kamal A
sanofi-aventis
Shterengarts Samanatha L
LandOfFree
Fluoropyrrolidines having dipeptidyl peptidase enzyme... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fluoropyrrolidines having dipeptidyl peptidase enzyme..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fluoropyrrolidines having dipeptidyl peptidase enzyme... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4173998